centenarian100 wrote:One would think that the number of new cases would go down with better risk stratification. Sadly, this does not seem to be the case
HarryZ wrote:Yes, it makes you wonder if the risk information is really getting to the patients before they make a decision. So often, MS patients will rely totally on what their doc/neuro tells them. Those who use the internet extensively have the ability obtain many points of view on Tysabri but I still believe this group is very small when compared to all MS patients.
439 is small compared to the total number of tysabri treated patients, but it is a terrible enough disease that it is still very concerning.
On Feb, 23, 2014: 90,305 people reported to have side effects when taking Tysabri. Among them, 2,583 people (2.86%) have PML.
But doesn't the FDA issue these kinds of reports? Aren't they required to let us know? No, and Yes.
The FDA issues quarterly FAERS (adverse effects) reports, which are about 25MB of data on ALL the drugs and all the side effects. They do not have a searchable site. It is not for consumers. They do not have a database. Here are the files. http://www.fda.gov/Drugs/GuidanceCompli ... 082193.htm
Users browsing this forum: No registered users